Drug Eluting Stents (DES) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4163907
- 139 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Drug Eluting Stents (DES) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Drug Eluting Stents (DES) market segmented into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
Based on the end-use, the global Drug Eluting Stents (DES) market classified into
Coronary Heart Disease
Clinical
Based on geography, the global Drug Eluting Stents (DES) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DRUG ELUTING STENTS (DES) INDUSTRY
2.1 Summary about Drug Eluting Stents (DES) Industry
2.2 Drug Eluting Stents (DES) Market Trends
2.2.1 Drug Eluting Stents (DES) Production & Consumption Trends
2.2.2 Drug Eluting Stents (DES) Demand Structure Trends
2.3 Drug Eluting Stents (DES) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cobalt-chromium alloy Stents
4.2.2 Magnesium alloy Stents
4.2.3 Tyrosine polycarbonate Stents
4.2.4 Nitinol Stents
4.2.5 Platinum chromium alloy Stents
4.2.6 Stainless steel Stents
4.2.7 Other Materials
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Coronary Heart Disease
4.3.2 Clinical
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cobalt-chromium alloy Stents
5.2.2 Magnesium alloy Stents
5.2.3 Tyrosine polycarbonate Stents
5.2.4 Nitinol Stents
5.2.5 Platinum chromium alloy Stents
5.2.6 Stainless steel Stents
5.2.7 Other Materials
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Coronary Heart Disease
5.3.2 Clinical
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cobalt-chromium alloy Stents
6.2.2 Magnesium alloy Stents
6.2.3 Tyrosine polycarbonate Stents
6.2.4 Nitinol Stents
6.2.5 Platinum chromium alloy Stents
6.2.6 Stainless steel Stents
6.2.7 Other Materials
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Coronary Heart Disease
6.3.2 Clinical
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cobalt-chromium alloy Stents
7.2.2 Magnesium alloy Stents
7.2.3 Tyrosine polycarbonate Stents
7.2.4 Nitinol Stents
7.2.5 Platinum chromium alloy Stents
7.2.6 Stainless steel Stents
7.2.7 Other Materials
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Coronary Heart Disease
7.3.2 Clinical
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cobalt-chromium alloy Stents
8.2.2 Magnesium alloy Stents
8.2.3 Tyrosine polycarbonate Stents
8.2.4 Nitinol Stents
8.2.5 Platinum chromium alloy Stents
8.2.6 Stainless steel Stents
8.2.7 Other Materials
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Coronary Heart Disease
8.3.2 Clinical
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cobalt-chromium alloy Stents
9.2.2 Magnesium alloy Stents
9.2.3 Tyrosine polycarbonate Stents
9.2.4 Nitinol Stents
9.2.5 Platinum chromium alloy Stents
9.2.6 Stainless steel Stents
9.2.7 Other Materials
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Coronary Heart Disease
9.3.2 Clinical
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Vascular
10.1.2 Advantec Vascular
10.1.3 B.Braun Melsengen AG
10.1.4 Biosensors
10.1.5 Biotronik
10.1.6 Blue Medical
10.1.7 Boston Scientific
10.1.8 DISA Vascular
10.1.9 Essen
10.1.10 Medtronic Vascular
10.1.11 MicroPort Medical
10.1.12 MIV Therapeutics
10.1.13 Orbusneich
10.1.14 Promed Medical
10.1.15 Relisys Medical
10.1.16 Reva Medical
10.1.17 Sahajanand
10.1.18 Sino Medical
10.1.19 Sorin
10.1.20 Terumo Medical
10.2 Drug Eluting Stents (DES) Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Vascular
10.2.2 Advantec Vascular
10.2.3 B.Braun Melsengen AG
10.2.4 Biosensors
10.2.5 Biotronik
10.2.6 Blue Medical
10.2.7 Boston Scientific
10.2.8 DISA Vascular
10.2.9 Essen
10.2.10 Medtronic Vascular
10.2.11 MicroPort Medical
10.2.12 MIV Therapeutics
10.2.13 Orbusneich
10.2.14 Promed Medical
10.2.15 Relisys Medical
10.2.16 Reva Medical
10.2.17 Sahajanand
10.2.18 Sino Medical
10.2.19 Sorin
10.2.20 Terumo Medical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Drug Eluting Stents (DES) Product Type Overview
2.Table Drug Eluting Stents (DES) Product Type Market Share List
3.Table Drug Eluting Stents (DES) Product Type of Major Players
4.Table Brief Introduction of Abbott Vascular
5.Table Brief Introduction of Advantec Vascular
6.Table Brief Introduction of B.Braun Melsengen AG
7.Table Brief Introduction of Biosensors
8.Table Brief Introduction of Biotronik
9.Table Brief Introduction of Blue Medical
10.Table Brief Introduction of Boston Scientific
11.Table Brief Introduction of DISA Vascular
12.Table Brief Introduction of Essen
13.Table Brief Introduction of Medtronic Vascular
14.Table Brief Introduction of MicroPort Medical
15.Table Brief Introduction of MIV Therapeutics
16.Table Brief Introduction of Orbusneich
17.Table Brief Introduction of Promed Medical
18.Table Brief Introduction of Relisys Medical
19.Table Brief Introduction of Reva Medical
20.Table Brief Introduction of Sahajanand
21.Table Brief Introduction of Sino Medical
22.Table Brief Introduction of Sorin
23.Table Brief Introduction of Terumo Medical
24.Table Products & Services of Abbott Vascular
25.Table Products & Services of Advantec Vascular
26.Table Products & Services of B.Braun Melsengen AG
27.Table Products & Services of Biosensors
28.Table Products & Services of Biotronik
29.Table Products & Services of Blue Medical
30.Table Products & Services of Boston Scientific
31.Table Products & Services of DISA Vascular
32.Table Products & Services of Essen
33.Table Products & Services of Medtronic Vascular
34.Table Products & Services of MicroPort Medical
35.Table Products & Services of MIV Therapeutics
36.Table Products & Services of Orbusneich
37.Table Products & Services of Promed Medical
38.Table Products & Services of Relisys Medical
39.Table Products & Services of Reva Medical
40.Table Products & Services of Sahajanand
41.Table Products & Services of Sino Medical
42.Table Products & Services of Sorin
43.Table Products & Services of Terumo Medical
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Drug Eluting Stents (DES) Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Drug Eluting Stents (DES) Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Drug Eluting Stents (DES) Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Drug Eluting Stents (DES) Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
